Eric Maller

561 total citations · 1 hit paper
12 papers, 437 citations indexed

About

Eric Maller is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Eric Maller has authored 12 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Eric Maller's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Eric Maller is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Eric Maller collaborates with scholars based in United States, Spain and Netherlands. Eric Maller's co-authors include Julián Panés, Peter Higgins, Wenjin Wang, Bruce E. Sands, Geert D’Haens, Jean‐Frédéric Colombel, Gary Chan, Wojciech Niezychowski, Michele Moscariello and Paul J. Healey and has published in prestigious journals such as Gastroenterology, Gut and The Journal of Pediatrics.

In The Last Decade

Eric Maller

12 papers receiving 431 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

2017 296 citations Julián Panés, William J. Sandborn et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Maller United States	6	251	152	124	105	85	12	437
Ignace Dalle Belgium	7	178 0.7×	193 1.3×	132 1.1×	60 0.6×	23 0.3×	14	410
Philip Ginsburg United States	9	110 0.4×	140 0.9×	136 1.1×	24 0.2×	71 0.8×	17	337
Takahiko Toyonaga Japan	13	253 1.0×	230 1.5×	104 0.8×	70 0.7×	46 0.5×	30	438
Omid Shaye United States	9	177 0.7×	147 1.0×	168 1.4×	61 0.6×	39 0.5×	11	428
Neerja Agrawal United States	8	20 0.1×	63 0.4×	64 0.5×	160 1.5×	84 1.0×	19	409
Chantal Eijsink Netherlands	12	36 0.1×	105 0.7×	155 1.3×	314 3.0×	18 0.2×	16	596
Ozay Halil United Kingdom	9	49 0.2×	79 0.5×	54 0.4×	38 0.4×	19 0.2×	14	368
Marylise Fort France	11	19 0.1×	81 0.5×	148 1.2×	125 1.2×	58 0.7×	24	521
Alan P. Grailer United States	9	65 0.3×	67 0.4×	211 1.7×	356 3.4×	11 0.1×	16	679
Lauro Vasconcellos United States	4	28 0.1×	111 0.7×	234 1.9×	198 1.9×	22 0.3×	6	536

Countries citing papers authored by Eric Maller

Since Specialization

Citations

This map shows the geographic impact of Eric Maller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Maller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Maller more than expected).

Fields of papers citing papers by Eric Maller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Maller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Maller. The network helps show where Eric Maller may publish in the future.

Co-authorship network of co-authors of Eric Maller

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Maller. A scholar is included among the top collaborators of Eric Maller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Maller. Eric Maller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Travis, Simon, Iris Dotan, Silvio Danese, et al.. (2020). P334 Impact of disease duration on tofacitinib efficacy in patients with ulcerative colitis. Journal of Crohn s and Colitis. 14(Supplement_1). S321–S323. 2 indexed citations

Dubinsky, Marla C., Marco DiBonaventura, Haiyun Fan, et al.. (2020). Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies. Inflammatory Bowel Diseases. 27(7). 983–993. 8 indexed citations

Sands, Bruce E., Adam S. Cheifetz, Chudy I. Nduaka, et al.. (2019). The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis. Journal of Crohn s and Colitis. 13(9). 1217–1226. 10 indexed citations

Rubin, David T., Daniel Quirk, Chudy I. Nduaka, et al.. (2019). DOP43 Long-term efficacy of tofacitinib in patients who received extended induction therapy: results of the OCTAVE open study for tofacitinib delayed responders. Journal of Crohn s and Colitis. 13(Supplement_1). S050–S052. 4 indexed citations

Melmed, Gil, Sam S. Chang, Haiyun Fan, et al.. (2019). 732 Laboratory Parameters Related to Monitoring in Patients With Ulcerative Colitis Treated With Tofacitinib for up to 3 Years in the OCTAVE Open-Label, Long-Term Extension Study. The American Journal of Gastroenterology. 114(1). S431–S431. 2 indexed citations

Panés, Julián, Brian Bressler, J F Colombel, et al.. (2018). P516 Efficacy and safety of tofacitinib retreatment for ulcerative colitis after treatment interruption: Results from the OCTAVE clinical trials. Journal of Crohn s and Colitis. 12(supplement_1). S366–S367. 5 indexed citations

Panés, Julián, William J. Sandborn, Stefan Schreiber, et al.. (2017). Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials. Gut. 66(6). 1049–1059. 296 indexed citations breakdown →

Dubinsky, Marla C., Laurent Peyrin‐Biroulet, Gil Melmed, et al.. (2017). Efficacy of Tofacitinib in Patients With Ulcerative Colitis by Prior Tumor Necrosis Factor Inhibitor Treatment Status: Results From OCTAVE Induction and Maintenance Studies. The American Journal of Gastroenterology. 112. S354–S354. 11 indexed citations

Panés, Julián, Geert D’Haens, Peter Higgins, et al.. (2017). Long-Term Safety and Tolerability of Oral Tofacitinib in Patients with Crohn’s Disease: Results from a Phase 2 Open-Label 48-Week Extension Study. Gastroenterology. 152(5). S599–S599. 3 indexed citations

10.

Abdelmalek, Manal F., Abhinav Humar, Felix Stickel, et al.. (2012). Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial. American Journal of Transplantation. 12(3). 694–705. 82 indexed citations

11.

Michna, Edward, et al.. (2011). The long-term efficacy of subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic nonmalignant pain. Journal of Pain. 12(4). P70–P70. 4 indexed citations

12.

Shneider, Benjamin L., et al.. (1989). Cholestasis in infants supported with extracorporeal membrane oxygenation. The Journal of Pediatrics. 115(3). 462–465. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact